J9210 Injection., emapalumab-lzsg, 1 milligrams
Also known as: emapalumab, Gamifant
Intravenous injection of emapalumab-lzsg, a human monoclonal antibody targeting interferon-gamma, dosed per 1 milligram.
In Plain Language
immune-regulating therapy; cytokine-blocking drug
Clinical Context
Used for primary hemophagocytic lymphohistiocytosis by blocking interferon-gamma-mediated immune activation.
RVU Information
CPT J9210 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9210?
CPT J9210 (Injection., emapalumab-lzsg, 1 milligrams) is a J Codes (Drugs) code. Intravenous injection of emapalumab-lzsg, a human monoclonal antibody targeting interferon-gamma, dosed per 1 milligram.
How is J9210 administered?
CPT J9210 is administered by a healthcare provider, typically via injection or infusion. Used for primary hemophagocytic lymphohistiocytosis by blocking interferon-gamma-mediated immune activation. It is used by Hematology, Immunology.
When is CPT J9210 used?
Used for primary hemophagocytic lymphohistiocytosis by blocking interferon-gamma-mediated immune activation.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.